Prakiraan volume dodolan Accuray Inc. (ARAY)
The conversion of global equipment orders for Accuray Incorporated (ARAY) remains stable, as confirmed by the projected sales volume dynamics on the GURU.Markets consolidated chart with a metric value of 0.39. Effective market expansion is constrained by R&D costs, while recurring service payments offset the volatility of one-off transactions, ensuring moderate cash flow predictability.
Rincian metrik keuangan lan pasar Accuray Inc. (ARAY)
- kuotasi lan prakiraan analis:
- rincian kapitalisasi pasar:
- informasi kapitalisasi buku:
- indikator beban kredit lan likuiditas emiten:
Utang marang Ekuitas Accuray Incorporated|ARAY - Koefisien utang jangka dawa marang modal|Utang jangka cendhak marang modal Accuray, Inc.|ARAY - Gunggung utang perusahaan|Utang marang nilai buku Accuray Inc|ARAY - Utang jangka dawa|Kewajiban jangka cendhak perusahaan Accuray Incorporated|Rasio cepet accuray.com
- statistik bathi lan rasio pasar:
ARAY - Asil keuangan resik|Bathi sing dikarepake Accuray Incorporated|ARAY - Pangali rega marang bathi|Pangali Forward P/E Accuray, Inc.|ARAY - Pangali rega marang bathi tumrap wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Accuray Inc|ARAY - Bathi sadurunge bunga, pajak, lan amortisasi|Bathi saben saham sajrone rolas wulan pungkasan Accuray Incorporated|ARAY - Bathi saben saham sajroning taun lumaku|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan accuray.com|ARAY - Dinamika bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Accuray Incorporated
- data total pendapatan lan volume dodolan:
Analisis komprehensif perusahaan:Accuray, Inc. ARAY
This metric assesses operational resilience by comparing revenue market expectations with industry-wide trends to identify hidden costs prior to official reports. By analyzing the future sales model of Accuray Incorporated (ARAY), an investor can discern real demand for high-precision radiation therapy systems, allowing them to filter out management optimism and timely recognize the risk of a "value trap" during an asset decline.
Pesaing Accuray Incorporated (ARAY)
Prakiraan volume dodolan ONC|HALO (Halozyme) - Pendapatan mangsa ngarep perusahaan|Prakiraan volume dodolan RVMD (revmed.com)|Dodolan mangsa ngarep perusahaan Ascentage (AAPG)|CGON: Volume dodolan mangsa ngarep perusahaan|Volume dodolan sing dikarepake perusahaan UroGen Pharma Ltd.|BCAX: Prakiraan volume dodolan|PSNL - Dodolan mangsa ngarep perusahaan|ERAS (Erasca Oncology) - Prakiraan volume dodolan|Prakiraan volume dodolan Delcath Systems, Inc.|Prakiraan pendapatan perusahaan ymabs.com (YMAB)|Prakiraan pendapatan perusahaan AURA (Aura Biosciences, Inc.)|Candel Therapeutics - Volume dodolan mangsa ngarep perusahaan|SELLAS Life Sciences Group Inc. - Prakiraan pendapatan perusahaan|ACTU: Volume dodolan mangsa ngarep perusahaan|Volume dodolan sing dikarepake perusahaan Citius Oncology Inc|HURA: Prakiraan volume dodolan|TARA: Prakiraan volume pendapatan perusahaan|FATE (fatetherapeutics.com) - Prakiraan volume dodolan|Volume dodolan mangsa ngarep perusahaan Aadi Bioscience Inc (WHWK)|Prakiraan volume dodolan TCRX|CSBR - Volume dodolan sing dikarepake perusahaan|Prakiraan volume dodolan XBIT (XBiotech Inc.)|CEL-SCI Corporation (CVM) - Volume dodolan sing dikarepake perusahaan|OSTX: Volume dodolan mangsa ngarep perusahaan|Pendapatan mangsa ngarep perusahaan RADX (Radiopharm Theranostics)|Artiva (ARTV) - Prakiraan pendapatan perusahaan|ANL: Prakiraan volume pendapatan perusahaan|VERU (Veru Corporation) - Prakiraan volume dodolan|Volume dodolan sing dikarepake perusahaan Tempest Therapeutics, Inc. TPST|Prakiraan volume dodolan XLO|Renovaro - Prakiraan pendapatan perusahaan|Prakiraan pendapatan perusahaan Mural Bio MURA|KAPA: Prakiraan pendapatan perusahaan|OnKure Therapeutics - Prakiraan volume dodolan|Dodolan mangsa ngarep perusahaan w2.cytomed.sg GDTC|CRIS: Prakiraan volume dodolan|Volume dodolan mangsa ngarep perusahaan Apollomics Inc.|THAR (Tharimmune Corporation) - Prakiraan volume dodolan|Prakiraan volume dodolan Advanced Biomed Inc|Prakiraan volume dodolan GNPX|Volume dodolan mangsa ngarep perusahaan Calidi Biotherapeutics Inc. CLDI|Prakiraan pendapatan perusahaan Sunshine Biopharma Inc. SBFM|Dodolan mangsa ngarep perusahaan Xenetic Biosciences (XBIO)|SLRX - Prakiraan pendapatan perusahaan|Volume dodolan sing dikarepake perusahaan Kitov Pharma|AON (AONC) - Prakiraan pendapatan perusahaan|Volume dodolan mangsa ngarep perusahaan BeiGene|Prakiraan pendapatan perusahaan checkpointtx.com|Prakiraan pendapatan perusahaan ELEV (Elevation Oncology)|Prakiraan volume dodolan ICAD|Ikena Oncology - Prakiraan pendapatan perusahaan|Prakiraan pendapatan perusahaan Notable Labs, Ltd. NTBL|VIRX: Prakiraan pendapatan perusahaan|MOR - Prakiraan pendapatan perusahaan|NAYA Bio (NAYA) - Volume dodolan mangsa ngarep perusahaan|AAPGV: Prakiraan volume dodolan
